Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+neuroblastoma cells undergo apoptosis following interaction with CD40L

被引:31
作者
Airoldi, I
Lualdi, S
Bruno, S
Raffaghello, L
Occhino, M
Gambini, C
Pistoia, V
Corrias, M
机构
[1] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy
[2] Ist Giannina Gaslini, Serv Pathol, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Expt Med, Sect Human Anat, Genoa, Italy
关键词
costimulatory molecules; human neuroblastoma; CD40; apoptosis; caspase-8;
D O I
10.1038/sj.bjc.6600951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour cells display low to absent expression of costimulatory molecules. Here, we have investigated the expression of costimulatory molecules (CD40, CD80, CD86, PD-1L, B7H2, OX40L and 4-1BBL) in human neuroblastoma ( NB) cells, since virtually no information is available on this issue. Both established NB cell lines and primary tumours were tested by RT - PCR and flow cytometry. Neuroblastoma cell lines expressed the transcripts of all costimulatory molecule genes, but not the corresponding proteins. Culture of NB cell lines with human recombinant (r) IFN-gamma induced surface expression of CD40 in half of them. Primary NB cells showed CD40, CD80, CD86, OX40L, 4-1BBL, but not PD-1L and B7H2, mRNA expression. Surface CD40 was consistently detected on primary NB cells by flow cytometry. Interferon-gamma gene-transfected NB cells expressed constitutively surface CD40 and were induced into apoptosis by incubation with rCD40L through a caspase-8-dependent mechanism. CD40 may represent a novel therapeutic target in NB.
引用
收藏
页码:1527 / 1536
页数:10
相关论文
共 51 条
  • [1] TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention
    Ahmad, M
    Shi, YF
    [J]. ONCOGENE, 2000, 19 (30) : 3363 - 3371
  • [2] Characterization of human inducible costimulator ligand expression and function
    Aicher, A
    Hayden-Ledbetter, M
    Brady, WA
    Pezzutto, A
    Richter, G
    Magaletti, D
    Buckwalter, S
    Ledbetter, JA
    Clark, EA
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (09) : 4689 - 4696
  • [3] Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells
    Airoldi, I
    Gri, G
    Marshall, JD
    Corcione, A
    Facchetti, P
    Guglielmino, R
    Trinchieri, G
    Pistoia, V
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (12) : 6880 - 6888
  • [4] Akiba H, 1999, J IMMUNOL, V162, P7058
  • [5] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [6] Expression and methylation of CASP8 in neuroblastoma:: Identification of a promoter region
    Banelli, B
    Casciano, I
    Croce, M
    Di Vinci, A
    Gelvi, I
    Pagnan, G
    Brignole, C
    Allemanni, G
    Ferrini, S
    Ponzoni, M
    Romani, M
    [J]. NATURE MEDICINE, 2002, 8 (12) : 1333 - 1335
  • [7] INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA
    BRODEUR, GM
    SEEGER, RC
    BARRETT, A
    BERTHOLD, F
    CASTLEBERRY, RP
    DANGIO, G
    DEBERNARDI, B
    EVANS, AE
    FAVROT, M
    FREEMAN, AI
    HAASE, G
    HARTMANN, O
    HAYES, FA
    HELSON, L
    KEMSHEAD, J
    LAMPERT, F
    NINANE, J
    OHKAWA, H
    PHILIP, T
    PINKERTON, CR
    PRITCHARD, J
    SAWADA, T
    SIEGEL, S
    SMITH, EI
    TSUCHIDA, Y
    VOUTE, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) : 1874 - 1881
  • [8] Bugajska U, 2002, J NATL CANCER I, V94, P1381
  • [9] 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
    Cannons, JL
    Lau, P
    Ghumman, B
    DeBenedette, MA
    Yagita, H
    Okumura, K
    Watts, TH
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1313 - 1324
  • [10] CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy
    Chambers, CA
    Kuhns, MS
    Egen, JG
    Allison, JP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 565 - 594